You are here : Home / Annual Results / SUN PHARMACEUTICAL INDUSTRIES LTD

SUN PHARMACEUTICAL INDUSTRIES Financials & Share Price [BOM: 524715|NSE : SUNPHARMA]

The Revenues of SUN PHARMACEUTICAL INDUSTRIES has increased by 2.01% YoY. The Earnings Per Share (EPS) of SUN PHARMACEUTICAL INDUSTRIES has decreased by -22.88 % YoY.
Y-o-Y REVENUES OPERATING MARGIN PROFIT AFTER TAX EPS ROCE Details👇

SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex

Current Share Price: ₹769.7, Current MarketCap: ₹184,674.1 Cr, Updated EOD on : Sep 24,2021
Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

-0.1%

-0.3%

47.1%

SENSEX

2.7%

7.3%

54.2%

What is the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES ?

SUN PHARMACEUTICAL INDUSTRIES Last 5 Annual Results
[BOM: 524715|NSE : SUNPHARMA]

ConsolidatedMar2021
Mar2020
Mar2019
Mar2018
Mar2017
Revenues ₹33,498 Cr₹32,838 Cr₹29,066 Cr₹26,416 Cr₹31,308 Cr
Expenses ₹25,030 Cr₹25,863 Cr₹22,792 Cr₹20,881 Cr₹21,626 Cr
Operating Profit (Excl OI) ₹8,468 Cr₹6,974 Cr₹6,274 Cr₹5,535 Cr₹9,682 Cr
Other Income ₹859 Cr₹652 Cr₹1,059 Cr₹912 Cr₹1,030 Cr
Interest ₹141 Cr₹303 Cr₹555 Cr₹518 Cr₹400 Cr
Depreciation ₹2,080 Cr₹2,053 Cr₹1,753 Cr₹1,500 Cr₹1,265 Cr
Profit Before Tax ₹2,799 Cr₹5,010 Cr₹3,810 Cr₹3,479 Cr₹9,048 Cr
Profit After Tax ₹2,285 Cr₹4,187 Cr₹3,209 Cr₹2,568 Cr₹7,836 Cr
Consolidated Net Profit ₹2,904 Cr₹3,765 Cr₹2,665 Cr₹2,096 Cr₹6,964 Cr
Earnings Per Share (Rs)₹12.10₹15.69₹11.11₹8.73₹29.03
PAT Margin (%)3.727.055.705.0224.82
ROE(%)4.989.668.056.8522.51
ROCE(%)5.6710.088.688.4021.48
Total Debt/Equity(x)0.080.180.250.270.27
Key Financials
Market Cap : ₹ 184,674.1 Cr
Revenue (TTM) : ₹ 35,631.6 Cr
Net Profit(TTM) : ₹ 6,123.1 Cr
EPS (TTM) : ₹ 25.5
P/E (TTM) : 30.2

Check out Industry Peers

Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES -0.1% -0.3% 47.1%
DIVIS LABORATORIES 1.7% 7.3% 53.8%
DR REDDYS LABORATORIES -1.9% 4.5% -9%
CIPLA 1.5% 5.5% 19.6%
GLAND PHARMA -1.6% 2.6% NA
PIRAMAL ENTERPRISES 5.6% 6.6% 95.6%
CADILA HEALTHCARE 1.6% 3.3% 37.2%
TORRENT PHARMACEUTICALS 0.2% 1.5% 7.4%
ALKEM LABORATORIES 5.7% 4.8% 38.4%

What is the Fundamental Analysis of SUN PHARMACEUTICAL INDUSTRIES ?

SUN PHARMACEUTICAL INDUSTRIES Revenues
[BOM: 524715|NSE : SUNPHARMA]

Revenues
Y-o-Y

2.01 %

5 Yr CAGR

1.70 %

Years Revenues % Change
Mar2021 ₹33,498 Cr
2.01
Mar2020 ₹32,838 Cr
12.98
Mar2019 ₹29,066 Cr
10.03
Mar2018 ₹26,416 Cr
-15.63
Mar2017 ₹31,308 Cr -
What is the Valuation of SUN PHARMACEUTICAL INDUSTRIES ?

SUN PHARMACEUTICAL INDUSTRIES Operating Profit
[BOM: 524715|NSE : SUNPHARMA]

Operating Profit
Y-o-Y

21.42 %

5 Yr CAGR

-3.30 %

Years Operating Profit % Change
Mar2021 ₹8,468 Cr
21.42
Mar2020 ₹6,974 Cr
11.17
Mar2019 ₹6,274 Cr
13.35
Mar2018 ₹5,535 Cr
-42.84
Mar2017 ₹9,682 Cr -
Operating Margins
Y-o-Y

19.02 %

5 Yr CAGR

-4.92 %

Years Operating Margin% % Change
Mar2021 25.28%
19.02
Mar2020 21.24%
-1.58
Mar2019 21.58%
3.01
Mar2018 20.95%
-32.27
Mar2017 30.93% -

SUN PHARMACEUTICAL INDUSTRIES Profit After Tax
[BOM: 524715|NSE : SUNPHARMA]

Profit After Tax(PAT)
Y-o-Y

-22.87 %

5 Yr CAGR

-19.64 %

Years Profit After Tax % Change
Mar2021 ₹2,904 Cr
-22.87
Mar2020 ₹3,765 Cr
41.25
Mar2019 ₹2,665 Cr
27.19
Mar2018 ₹2,096 Cr
-69.91
Mar2017 ₹6,964 Cr -
PAT Margins
Y-o-Y

-47.23 %

5 Yr CAGR

-37.78 %

Years PAT Margin(%) % Change
Mar2021 3.72 %
-47.23
Mar2020 7.05 %
23.68
Mar2019 5.7 %
13.55
Mar2018 5.02 %
-79.77
Mar2017 24.82 % -

SUN PHARMACEUTICAL INDUSTRIES Earnings Per Share (EPS)
[BOM: 524715|NSE : SUNPHARMA]

EPS
Y-o-Y

-22.88 %

5 Yr CAGR

-19.65 %

Years EPS % Change
Mar2021 ₹12
-22.88
Mar2020 ₹16
41.22
Mar2019 ₹11
27.26
Mar2018 ₹8.73
-69.93
Mar2017 ₹29 -

SUN PHARMACEUTICAL INDUSTRIES Return on Capital Employed (ROCE)
[BOM: 524715|NSE : SUNPHARMA]

ROCE
Y-o-Y

-43.75 %

5 Yr CAGR

-28.32 %

Years ROCE % Change
Mar2021 5.67%
-43.75
Mar2020 10.08%
16.13
Mar2019 8.68%
3.33
Mar2018 8.4%
-60.89
Mar2017 21.48% -
What is the Valuation of SUN PHARMACEUTICAL INDUSTRIES ?

SUN PHARMACEUTICAL INDUSTRIES related INDICES

BSE Indices1W1M1Y
S&P BSE DIVIDEND STABILITY 3% 7.3% 49.6%
S&P BSE SENSEX 2.7% 7.3% 54.2%
S&P BSE SENSEX50 2.6% 7.2% 54.8%
S&P BSE LARGECAP 2.5% 7.3% 54.6%
S&P BSE LARGE MIDCAP 2.5% 7.6% 56.6%
S&P BSE 100 2.5% 7.4% 55.5%
S&P BSE CARBONEX 2.5% 7.2% 54.9%
S&P BSE 250 LARGEMIDCAP 2.5% 7.6% 57.8%
S&P BSE 200 2.5% 7.6% 57.5%
S&P BSE 100 LARGECAP TMC 2.5% 7.4% 55.3%
S&P BSE 500 2.5% 7.7% 59.1%
S&P BSE ALLCAP 2.4% 7.7% 60.1%
S&P BSE GREENEX 2.4% 6.9% 56%
S&P BSE 500 SHARIAH 2.1% 7.4% 58.6%
S&P BSE 100 ESG INDEX 2.1% 6.5% 54.7%
MFG 1.6% 5.8% 41.7%
S&P BSE HEALTHCARE 0.4% 1.9% 30.3%
NSE Indices1W1M1Y
NIFTY 50 2.6% 7.3% 54.9%
NIFTY 200 2.5% 7.8% 57.6%
NIFTY LARGE MIDCAP 250 2.5% 8.3% 63.2%
NIFTY 100 2.5% 7.5% 55.4%
NIFTY 500 2.5% 7.8% 59.1%
NIFTY50 EQUAL WEIGHT 2.4% 7.5% 65.3%
NIFTY500 MULTICAP 50:25:25 2.4% 8.1% NA
NIFTY100 LIQ 15 2.3% 8% 63.2%
NIFTY 100 EQUAL WEIGHT 2.2% 7.9% 63.1%
NIFTY PHARMA 1.4% 3.3% 16.7%
NIFTY HEALTHCARE 0.6% 1.5% NA

FAQ [Frequently Asked Questions]


What is the share price of SUN PHARMACEUTICAL INDUSTRIES ?

The current share price of SUN PHARMACEUTICAL INDUSTRIES is ₹ 769.7.

What are the share price returns of SUN PHARMACEUTICAL INDUSTRIES ?

The share price returns of SUN PHARMACEUTICAL INDUSTRIES are as under:
1 Week : -0.1%
1 Month : -0.3%
1 Year : 47.1%

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of GLAND PHARMA LTD
Quarterly Results of PIRAMAL ENTERPRISES LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of ALKEM LABORATORIES LTD
Quarterly Results of LUPIN LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of ABBOTT INDIA LTD
Quarterly Results of LAURUS LABS LTD
Quarterly Results of IPCA LABORATORIES LTD

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z